
New Key Publication: Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression

Small molecule inhibitors directed against the RAS-MAPK pathway are used to treat various malignancies, but side effects can result in treatment interruption, morbidity, and mortality. We show that short-term MEK inhibition deregulates the expression of genes involved in bile acid metabolism and consequently causes profound alterations in bile acid metabolism. Our work contributes to understanding the initial mechanisms by which RAS MAPK inhibitors can cause gastrointestinal complications, hepatotoxicity, and related side effects.
Authors:
- Cristy R.C. Verzijl
- Ivo P. van de Peppel
- Roos E. Eilers
- Vincent W. Bloks
- Justina C. Wolters
- Martijn Koehorst
- Niels J. Kloosterhuis
- Rick Havinga
- Mathilde Jalving
- Dicky Struik
- Johan W. Jonker
Read more: Biomedicine & Pharmacotherapy: https://www.sciencedirect.com/science/article/pii/S0753332223000586
Last modified: | 19 January 2023 7.25 p.m. |
More news
-
15 December 2022
Groningen contributes to major research initiative into energy-efficient information technology
The Dutch science funding agency NWO recently awarded a large research project into new concepts for energy-efficient information technology of no less than ten million euros
-
05 December 2022
Frans J. Sijtsma new Director Agricola School
On the recommendation of the Board of the University of Groningen, Dr Frans J. Sijtsma has been appointed as academic director of the Rudolf Agricola School for Sustainable Development with effect from 1 February 2023. This concerns a 0.5 FTE...
-
29 November 2022
Science Shops: bridging the gap between university and society
Science shops. What kinds of things can you buy there? A knowledge sandwich? A wisdom smoothie? Bacteria on demand? It is not clear to everyone what science shops have to offer. And yet, they play an important role for society, researchers, and...